MedPath

Corneal Cross Linking and Topography Guided Excimer Laser Treatment

Phase 3
Terminated
Conditions
Keratoconus
Pellucid Marginal Degeneration
Interventions
Other: Corneal Cross Linking
Other: Topography guided Excimer Laser treatment and Corneal Cross Linking
Registration Number
NCT01682993
Lead Sponsor
Medical University of Vienna
Brief Summary

Topography guided laser treatment enables the surgeon to correct higher order aberrations in corneas with irregular astigmatism. Several case reports and small uncontrolled trials have been published on the combination of this treatment with corneal cross linking (CCL) in patients with ectatic corneal diseases.

This randomized study will evaluate the safety and efficacy of a combined treatment of corneal cross linking with a partial topography guided excimer laser treatment in eyes with progressive ectatic corneal diseases.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Signed informed consent
  • Patient age 18 - 40 years
  • Documented progressive corneal ectatic disease except post LASIK/LASEK ectasia
Read More
Exclusion Criteria
  • Allergy to one of the used substances
  • Tendency towards excessive scar formation
  • Pregnancy
  • Rheumatic diseases
  • Central corneal thickness below 450 µm
  • Active infection of the study eye
  • Previous corneal surgery of the study eye
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Corneal Cross LinkingCorneal Cross LinkingPatients will receive a standard corneal cross linking treatment
Corneal Cross Linking and Topo LaserTopography guided Excimer Laser treatment and Corneal Cross LinkingPatients will receive a topography guided laser treatment in combination with a standard corneal cross linking treatment in the same session.
Primary Outcome Measures
NameTimeMethod
Safety (Pachymetry, K-readings)1 year
uncorrected visual acuity (UVCA)1 year
best corrected visual acuity (BCVA)1 year
Secondary Outcome Measures
NameTimeMethod
Progression of ectatic disease (by use of maximum keratometry readings = Kmax)1 year

Trial Locations

Locations (1)

Medical University of Vienna, Department of Ophthalmology

🇦🇹

Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath